Pediatric Opioids And Pain Control In Fractures Overview It has been observed over time that pediatric patients who go through a closed reduction of fractures to the forearm with standard sedation in the emergency room are given opioids around 14 times the normal amount used at discharge. It has also been observed
Tag: pediatric
Pediatric Oncology: Diagnosis And Prognosis Communication
Pediatric Oncology: Diagnosis And Prognosis Communication Overview When a child is diagnosed with cancer, it is an incredibly difficult situation for everyone in the family, and the parents especially have a hard time understanding the complicated details of the diagnosis and outcome. They usually want doctors to be honest and transparent, though
Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia
Carfilzomib Therapy in Pediatric Acute Lymphoblastic Leukemia Overview In this study, the safety and tolerability of a combination of carfilzomib and vincristine, dexamethasone, asparaginase, and daunorubicin (VXLD) were assessed in children with relapsed and/or refractory acute lymphoblastic leukemia (ALL). ALL is the most common cancer diagnosed in childhood and survival for patients
nusinersen therapy for pediatric spinal muscular atrophy
nusinersen therapy for pediatric spinal muscular atrophy Study Background Spinal muscular atrophy (SMA) is an inherited motor neuron disease caused by the degeneration of anterior horn cells of the spinal cord and brainstem. SMA primarily affects babies and young children and has an incidence of 1:10,000. It is caused by a homozygous
pediatric liver transplantation: a new biological abdominal wall
pediatric liver transplantation: a new biological abdominal wall Study Background Liver transplantation (LT) is the only definitive treatment for children with advanced liver disease. Pediatric liver transplantation has evolved significantly over the past few decades, with excellent short-term and long-term survival rates. However, graft matching challenges, especially size-matched donors, remain. Also, in
pediatric leukemia patients utilizing levofloxacin
pediatric leukemia patients utilizing levofloxacin STUDY BACKGROUND Bacterial infection-related morbidity and mortality are high in children treated for acute myeloid leukemia (AML) and relapsed acute lymphoblastic leukemia (rALL). Bacteremia not only contributes to mortality but also prolongs hospitalization, delays chemotherapy, decreases the quality of life, and requires the administration of costly and
